NYSE · traded in Congress
Ciena CIEN
$241.2814 -2.1086 (-0.87%) Nov 9, 2026 4:26 AM ET
Market value$34.2B
P/E ratio-
Analyst target$549.00
52-week range-
Avg volume2,245,774
Dividend yield-
Chart
Analyst ratings
- 19 buy
- 5 hold
- 0 sell
Low target$347.00
Average target$520.25
High target$660.00
Quarterly financials
| Quarter ended | Revenue | Gross profit | Net income | Net margin |
|---|---|---|---|---|
| $1,671M | $759M | $266M | 15.9% | |
| $1,571M | $692M | $218M | 13.9% | |
| $1,427M | $626M | $150M | 10.5% | |
| $1,352M | $577M | $19M | 1.4% |
Congress trades in CIEN
Members of Congress disclosed 2 transactions in CIEN in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 05/29/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 6/8/2026 filing |
| 05/14/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 6/8/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Our coverage
- US offers up to $20 million and relocation for tips on Iran's nuclear program War Room · November 7, 2026
- RFK Jr. clears 6 unapproved peptides for compounding as FDA scientists warn on safety Stocks · October 28, 2026
- Integra LifeSciences falls 21% on a $30 million guidance cut; $1.6 billion of net debt is why it hurt Stocks · October 2, 2026
- Kodiak Sciences stock up 155% after eye-drug trial wins; the data shows "as good as" the standard, not better Stocks · September 28, 2026
- Arcturus calls its OTC deficiency data encouraging; the Phase 2 had seven evaluable patients and no placebo Stocks · September 23, 2026
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView; options activity, ratings, financials, earnings and filings refreshed through the day. Congressional trades parsed from official House filings. Market information, not investment advice.
